Aetna Inc. (AET) Stake Decreased by BNP Paribas Arbitrage SA
BNP Paribas Arbitrage SA decreased its stake in Aetna Inc. (NYSE:AET) by 54.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,751 shares of the company’s stock after selling 34,783 shares during the period. BNP Paribas Arbitrage SA’s holdings in Aetna were worth $3,319,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust raised its position in Aetna by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 829 shares of the company’s stock valued at $101,000 after buying an additional 73 shares in the last quarter. Hartford Financial Management Inc. raised its position in Aetna by 304.8% in the second quarter. Hartford Financial Management Inc. now owns 850 shares of the company’s stock valued at $101,000 after buying an additional 640 shares in the last quarter. Acrospire Investment Management LLC raised its position in Aetna by 37.3% in the second quarter. Acrospire Investment Management LLC now owns 1,105 shares of the company’s stock valued at $135,000 after buying an additional 300 shares in the last quarter. FirstMerit Bank N A Trustee bought a new position in shares of Aetna during the second quarter worth approximately $200,000. Finally, Genesee Valley Trust Co. bought a new position in shares of Aetna during the second quarter worth approximately $203,000. Institutional investors own 88.28% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded up 2.84% during trading on Tuesday, reaching $132.03. 2,914,015 shares of the company’s stock traded hands. The company’s 50-day moving average is $115.34 and its 200 day moving average is $116.60. Aetna Inc. has a 52-week low of $92.42 and a 52-week high of $132.57. The company has a market cap of $46.33 billion, a price-to-earnings ratio of 19.04 and a beta of 0.54.
Aetna (NYSE:AET) last posted its earnings results on Thursday, October 27th. The company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $2.02 by $0.05. The firm earned $15.78 billion during the quarter, compared to the consensus estimate of $15.71 billion. Aetna had a net margin of 3.91% and a return on equity of 16.25%. The company’s revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the company earned $1.90 earnings per share. Equities analysts forecast that Aetna Inc. will post $8.02 EPS for the current year.
WARNING: This article was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2016/11/29/aetna-inc-aet-stake-decreased-by-bnp-paribas-arbitrage-sa.html.
A number of brokerages recently commented on AET. Zacks Investment Research upgraded shares of Aetna from a “sell” rating to a “hold” rating in a research note on Tuesday, November 22nd. FBR & Co reiterated a “hold” rating on shares of Aetna in a research note on Wednesday, August 17th. Credit Suisse Group AG reiterated a “hold” rating and issued a $120.00 price target on shares of Aetna in a research note on Wednesday, August 17th. Jefferies Group reiterated a “hold” rating on shares of Aetna in a research note on Tuesday, August 23rd. Finally, Sanford C. Bernstein lowered shares of Aetna from an “outperform” rating to a “market perform” rating and set a $132.00 price target on the stock. in a research note on Monday, November 14th. Seven equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Aetna currently has a consensus rating of “Buy” and a consensus price target of $132.14.
In other news, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total value of $827,221.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.90% of the stock is currently owned by insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.